Ghrelin, leptin and adiponectin levels in Gaucher disease type I patients on enzyme replacement therapy
- 30 August 2014
- journal article
- Published by Elsevier in Clinical Nutrition
- Vol. 34 (4) , 727-731
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Gaucher disease: haematological presentations and complicationsBritish Journal of Haematology, 2014
- Gaucher Disease: A Comprehensive ReviewCritical Reviews™ in Oncogenesis, 2013
- Gaucher disease type I: Assessment of basal metabolic rate in patients from southern BrazilBlood Cells, Molecules, and Diseases, 2011
- Hyperferritinemia and iron overload in type 1 Gaucher diseaseAmerican Journal of Hematology, 2010
- A cross-sectional, mono-centric pilot study of insulin resistance in enzyme replacement therapy patients with Gaucher type I without overweightMolecular Genetics and Metabolism, 2009
- Type I Gaucher Disease, a Glycosphingolipid Storage Disorder, Is Associated with Insulin ResistanceThe Journal of Clinical Endocrinology & Metabolism, 2008
- Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: Correlations with disease severity and response to therapeutic interventionBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemiaMetabolism, 2007
- Differential Effects of Enzyme Supplementation Therapy on Manifestations of Type 1 Gaucher DiseaseThe American Journal of Medicine, 1997
- Resting energy expenditure in Gaucher's disease type 1: Effect of Gaucher's cell burden on energy requirementsMetabolism, 1989